Viewing StudyNCT00026338



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00026338
Status: COMPLETED
Last Update Posted: 2020-04-02
First Post: 2001-11-09

Brief Title: Gemcitabine WithOut Erlotinib in Unresectable Locally AdvancedMetastatic Pancreatic Cancer
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Organization Data

Organization: Canadian Cancer Trials Group
Class: NETWORK
Study ID: PA3
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: NCIC Clinical Trials Group
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators